Jitlada Austin
Nurse Practitioner · Dublin, CANPI 1730743345
Payments from drug & device makers
Across 219 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$526
- AstraZeneca$383
- Seagen Inc.$330
- Merck$279
- Johnson & Johnson$276
- Takeda Pharmaceuticals U.S.A., Inc.$264
- plus $3K from 41 others
What the payments were for
- Food & beverage$4,70693%
- Education$3697%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,074 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exemestane | 48 | $3,901 |
| Anastrozole | 97 | $2,693 |
| Letrozole | 84 | $1,865 |
| Gabapentin | 19 | $244 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Dublin
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.